Impact of cyp2c9 and vkorc1 genes polymorphism to the therapeutic dose of warfarin in patients with atrial fibrillation
dc.contributor.author | Akpanova, D. | |
dc.contributor.author | Berkinbayev, S. | |
dc.contributor.author | Ospanova, D. | |
dc.contributor.author | Musagaliyeva, A. | |
dc.date.accessioned | 2017-09-19T11:23:31Z | |
dc.date.available | 2017-09-19T11:23:31Z | |
dc.date.issued | 2017-09-15 | |
dc.identifier.citation | Akpanova, D. et al.(2017) Impact of cyp2c9 and vkorc1 genes polymorphism to the therapeutic dose of warfarin in patients with atrial fibrillation. National Laboratory Astana, Nazarbayev University | ru_RU |
dc.identifier.uri | http://nur.nu.edu.kz/handle/123456789/2621 | |
dc.language.iso | en | ru_RU |
dc.publisher | National Laboratory Astana, Nazarbayev University | ru_RU |
dc.rights | Open Access - the content is available to the general public | ru_RU |
dc.rights | Attribution-NonCommercial-ShareAlike 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/us/ | * |
dc.subject | atrial fibrillation | ru_RU |
dc.subject | warfarin | ru_RU |
dc.subject | gene polymorphism | ru_RU |
dc.title | Impact of cyp2c9 and vkorc1 genes polymorphism to the therapeutic dose of warfarin in patients with atrial fibrillation | ru_RU |
dc.type | Abstract | ru_RU |